Open Book Extracts

Activities: Ingredients

Trending Articles

  1. Nutraceutical Business Review Stand Side with Mibelle Biochemistry We discover what exhibitors at SupplySide Global 2025 are showcasing LIVE!
  2. IFF sells Food Ingredients business to CVC Capital Partners in $4.3bn deal IFF has agreed to divest its Food Ingredients division to private equity firm CVC Capital Partners for approximately $4.3, as the flavours and fragrances giant restructures its...
  3. Rejuvant outperforms 83 supplements in landmark longevity study — including NMN, NR and standard AKG A new study found that Rejuvant, a delayed-release calcium alpha-ketoglutarate (CaAKG) supplement, was the only compound among 84 tested to achieve statistically significant...
  4. As omega-3 innovation evolves, brands are exploring new phospholipid systems beyond traditional krill oil NBR spoke to Naturmega about the emergence of next-generation phospholipid omega-3 solutions, changing market expectations and why the future of omega innovation may...
  5. ZeroLyte hydrates twice as fast as water in first sugar-free electrolyte clinical trial ASU's Hydration Science Lab confirms Trace Minerals' ZeroLyte improves post-exercise fluid retention at every measured time point — a clinically validated edge for sports...

Upcoming event

World of Plant Extracts Expo 2026

24–26 August 2026 | Exhibition | Xi'an, China See all

Related Content

Ingredients

Open Book Extracts (OBX) announces founding membership in ONE HEMP

Since the inception of Open Book Extracts (OBX) in 2019, the company has served as a leader in the hemp-based CBD market, prioritising science, safety, and responsible commerce
Ingredients

OBX launches trial for minor cannabinoid formulations

The cannabinoids selected were CBD, CBG, CBC, and CBDV, and the polyphenols selected were Quercetin and Curcumin
Finance

OBX receives strategic investment from Btomorrow Ventures

The two companies have signed a scientific collaboration agreement covering areas of future R&D
Ingredients

Open Book Extracts expands capabilities and management team to boost finished goods manufacturing

The expansion will serve to address increased demand for the company’s product development and manufacturing services
Regulatory

OBX announces results of Phase I toxicology assessment

The company contracted AIBMR Life Sciences to conduct the studies investigating the safety of consuming its CBG, CBN, and CBC products
Ingredients

OBX completes trial of cannabinoids for pain relief

Results from the pain study are expected in late April 2022 and will be announced at that time
Ingredients

Open Book Extracts appoints European sales leadership

In March 2021, OBX became a member of the European Industrial Hemp Association Novel Food Consortium
Subscribe now